Loading people...
Michael Lütolf is a biomedical engineer and biotechnology professional whose work primarily centers on the specialized fields of bioelectronics and nanoscience. He holds a Master of Science in Biomedical Engineering and Bioelectronics from ETH Zürich, where he previously earned his Bachelor of Science in Biotechnology. To further expand his technical foundation, he completed advanced studies in biomedical engineering at Columbia University and undertook coursework in nanoscience and physics at the University of Basel. Throughout his professional trajectory, he has consistently focused on bridging formal academic research with practical industry applications within the health technology sector. His technical expertise involves developing applied cross-disciplinary solutions situated at the intersection of advanced engineering principles and biological sciences. Lütolf maintains a current focus on advancing biomedical engineering initiatives that leverage his academic background to address emerging challenges in the biotechnology landscape.
Michael Lütolf is Investor at Verve Ventures, based in Berlin, Germany.